The risks associated with pre-market and after-hours trading may be slightly higher than the regular market hours. The reason is that extended-hours trading may result in wider spreads for particular security due to lower liquidity and higher volatility as issuers often announce critical financial information outside regular trading hours. After-hours trades for American Well Corporation (AMWL) shows that investor sentiment remained broken, with the stock’s consolidated last price falling by -$0.08, or -2.11%, to $3.71. Volume reached 23,699 shares, with price reaching a high of $3.73 and a low of $3.69. The stock was recently discussed on Yahoo Finance as it revealed that Amwell Extends Technology Leadership Team.
American Well Corporation is listed on the NYSE as a member of the Healthcare sector and is a part of the Health Information Services industry. At the end of the last regular session, the stock closed at $3.73 and fluctuated between $3.8600 as its day high and $3.6800 as its day low. The current market capitalization of American Well Corporation is $1.04B. A total of 1.4 million shares were traded on the day, compared to an average of 1.71M shares.
Additionally, investors take into account insider trades when predicting how a stock will perform. During the recent three months, AMWL has seen 2 BUY and 14 SELL insider trades, representing the acquisition of 955,106 and the disposition of 431,502 shares. Over the last 12 months, there were 22 BUYs and 85 SELLs from insiders. Insiders purchased 4,881,795 shares during that period but sold 3,093,320.
In the most recent transaction, Schoenberg Ido sold 50,943 shares of AMWL for 4.25 per share on Sep 12. After the transaction, the Chairman, co-CEO now owns 1,752,870 company shares. In a previous transaction on Sep 09, Schoenberg Ido sold 259,000 shares at 4.36 per share. AMWL shares that Chairman, co-CEO owns now total 1,803,813.
Among the insiders who sold shares, Shepardson Robert disposed of 20,000 shares on Sep 08 at a per-share price of $4.05. This resulted in the Chief Financial Officer holding 918,692 shares of AMWL after the transaction. In another insider transaction, Gay Bradford sold 14,193 shares at $4.01 per share on Sep 07. Company shares held by the Senior VP, General Counsel now total 796,083.
Though price targets are rarely accurate, they can exert some influence from time to time and were often accepted as valuable by the market. According to analysts who have offered 12-month price targets for AMWL in the last 3 months, the mean price target is $5.14 with high estimates of $9.00 and low estimates of $4.00. In terms of 52-week highs and lows, AMWL has a high of $10.60 and a low of $2.52.
As of this writing, AMWL has an earnings estimate of $-0.26 per share for the current quarter. EPS was calculated based on a consensus of 5 estimates, with a high estimate of $-0.23 per share and a lower estimate of $-0.28.
Balance Sheet Annually/Quarterly
A balance sheet is a report that shows the company’s assets and liabilities. In addition, it shows how much equity investors have invested in the company. Investors can determine the company’s prospects by calculating its financial ratios based on this information. AMWL’s latest balance sheet shows that the firm has $746.42M in Cash & Short Term Investments as of fiscal 2021. There were $16.61M in debt and $141.63M in liabilities at the time. Its Book Value Per Share was $4.17, while its Total Shareholder’s Equity was $1.26B.
It may be riskier to trade before market opening and after market closing than during regular market hours. Since issuers often announce critical financial information outside regular trading hours. Extended-hours trading may result in wider spreads for particular securities due to lower liquidity and higher volatility. Currently, 16 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for AMWL is Underweight with a score of 3.70. A total of 4 analysts rated the stock as Buy while 0 rated it as Overweight while 12 rated it as Hold. Among the other participants, 0 thought the stock was Underweight and 0 thought it should be Sold.